CCM Investment Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Sell |
119,479
-1,943
| -2% | -$186K | 0.99% | 47 |
|
|
2025
Q4 | $11.7M | Sell |
121,422
-2,110
| -2% | -$205K | 1.12% | 47 |
|
|
2025
Q3 | $11.8M | Buy |
123,532
+30,939
| +33% | +$2.84M | 1.16% | 44 |
|
|
2025
Q2 | $8.07M | Buy |
+92,593
| New | +$7.85M | 0.87% | 51 |
|
|
2022
Q4 | – | Sell |
-2,919
| Closed | -$235K | – | 73 |
|
|
2022
Q3 | $235K | Sell |
2,919
-297
| -9% | -$26.7K | 0.04% | 64 |
|
|
2022
Q2 | $288K | Sell |
3,216
-155
| -5% | -$15.7K | 0.05% | 62 |
|
|
2022
Q1 | $374K | Sell |
3,371
-104,051
| -97% | -$11M | 0.05% | 61 |
|
|
2021
Q4 | $11.1M | Buy |
107,422
+3,572
| +3% | +$414K | 1.35% | 48 |
|
|
2021
Q3 | $13M | Sell |
103,850
-127
| -0.1% | -$16.4K | 1.69% | 31 |
|
|
2021
Q2 | $12.9M | Buy |
103,977
+241
| +0.2% | +$30.3K | 1.65% | 33 |
|
|
2021
Q1 | $12.3M | Sell |
103,736
-187
| -0.2% | -$21.9K | 1.66% | 29 |
|
|
2020
Q4 | $12.2M | Sell |
103,923
-576
| -0.6% | -$63.4K | 1.76% | 23 |
|
|
2020
Q3 | $10.9M | Sell |
104,499
-2,127
| -2% | -$214K | 1.76% | 28 |
|
|
2020
Q2 | $9.78M | Sell |
106,626
-4,533
| -4% | -$435K | 1.67% | 33 |
|
|
2020
Q1 | $10M | Sell |
111,159
-10,320
| -8% | -$1.1M | 2% | 23 |
|
|
2019
Q4 | $13.8M | Sell |
121,479
-7,376
| -6% | -$809K | 2.15% | 14 |
|
|
2019
Q3 | $14M | Sell |
128,855
-2,891
| -2% | -$302K | 2.3% | 10 |
|
|
2019
Q2 | $12.8M | Sell |
131,746
-5,844
| -4% | -$534K | 2.16% | 14 |
|
|
2019
Q1 | $12.5M | Buy |
137,590
+3,805
| +3% | +$341K | 2.1% | 16 |
|
|
2018
Q4 | $12.2M | Buy |
133,785
+14,009
| +12% | +$1.31M | 2.42% | 12 |
|
|
2018
Q3 | $11.8M | Sell |
119,776
-1,481
| -1% | -$137K | 2.17% | 12 |
|
|
2018
Q2 | $10.4M | Buy |
121,257
+5,325
| +5% | +$445K | 1.98% | 22 |
|
|
2018
Q1 | $9.3M | Buy |
115,932
+2,360
| +2% | +$195K | 1.81% | 27 |
|
|
2017
Q4 | $9.17M | Sell |
113,572
-272
| -0.2% | -$21.8K | 1.77% | 32 |
|
|
2017
Q3 | $8.85M | Sell |
113,844
-2,475
| -2% | -$205K | 1.7% | 33 |
|
|
2017
Q2 | $10.3M | Buy |
116,319
+5,400
| +5% | +$455K | 2.02% | 12 |
|
|
2017
Q1 | $8.94M | Buy |
110,919
+2,271
| +2% | +$177K | 1.78% | 19 |
|
|
2016
Q4 | $7.74M | Sell |
108,648
-4,598
| -4% | -$361K | 1.63% | 34 |
|
|
2016
Q3 | $9.78M | Sell |
113,246
-141,414
| -56% | -$12.3M | 2.07% | 15 |
|
|
2016
Q2 | $22.1M | Sell |
254,660
-22,758
| -8% | -$1.84M | 2.06% | 10 |
|
|
2016
Q1 | $20.8M | Sell |
277,418
-24,359
| -8% | -$1.83M | 1.95% | 15 |
|
|
2015
Q4 | $23.2M | Buy |
301,777
+20,554
| +7% | +$1.55M | 2.18% | 17 |
|
|
2015
Q3 | $18.8M | Sell |
281,223
-1,211
| -0.4% | -$89.2K | 1.87% | 25 |
|
|
2015
Q2 | $20.9M | Buy |
282,434
+28,514
| +11% | +$2.18M | 1.93% | 21 |
|
|
2015
Q1 | $19.8M | Sell |
253,920
-50,705
| -17% | -$3.84M | 1.93% | 16 |
|
|
2014
Q4 | $22M | Buy |
304,625
+938
| +0.3% | +$65.2K | 2% | 19 |
|
|
2014
Q3 | $18.8M | Buy |
303,687
+5,714
| +2% | +$363K | 1.68% | 35 |
|
|
2014
Q2 | $19M | Sell |
297,973
-18,564
| -6% | -$1.13M | 1.74% | 30 |
|
|
2014
Q1 | $19.5M | Sell |
316,537
-10,933
| -3% | -$637K | 1.93% | 24 |
|
|
2013
Q4 | $18.8M | Buy |
327,470
+20,861
| +7% | +$1.18M | 1.76% | 23 |
|
|
2013
Q3 | $16.3M | Buy |
306,609
+56,859
| +23% | +$3.06M | 1.62% | 25 |
|
|
2013
Q2 | $12.9M | Buy |
+249,750
| New | +$12.3M | 1.32% | 35 |
|
Other funds holding MDT
VCM
VPM
CCM Investment Advisers's MDT Position: Q1 2026 in Review
CCM Investment Advisers reduced its Medtronic (MDT) stake by 1.6% in Q1 2026, selling an estimated $186K and leaving 119,479 shares worth $10.4M. The position accounts for 0.99% of the portfolio, ranked #47.
CCM Investment Advisers first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $23.2M in Q4 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- CCM Investment Advisers held 119,479 shares of Medtronic worth $10.4M as of Q1 2026.
- CCM Investment Advisers sold 1,943 Medtronic shares in Q1 2026, an estimated $186K.
- Medtronic made up 0.99% of CCM Investment Advisers's portfolio in Q1 2026, its #47 holding.
- CCM Investment Advisers first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
- CCM Investment Advisers's Medtronic position peaked at $23.2M in Q4 2015.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on CCM Investment Advisers's 13F filing for Q1 2026, filed 20 May 2026.